117 related articles for article (PubMed ID: 14734236)
1. Rapid diagnosis of acute promyelocytic leukemia (PML): applicability of flow cytometry and PML protein immunofluorescence.
Cullen MJ; Richards SJ; O'Connor SJ; Dickinson H; Sharpe C; Swirsky DM; Owen R
Cancer Genet Cytogenet; 2004 Jan; 148(2):176-7. PubMed ID: 14734236
[No Abstract] [Full Text] [Related]
2. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
[TBL] [Abstract][Full Text] [Related]
3. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
[TBL] [Abstract][Full Text] [Related]
4. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.
Dimov ND; Medeiros LJ; Kantarjian HM; Cortes JE; Chang KS; Bueso-Ramos CE; Ravandi F
Cancer; 2010 Jan; 116(2):369-76. PubMed ID: 19950129
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3.
Alayed KM; Medeiros LJ; Phan D; Ojiaku C; Patel J; Yap JP; McCord Y; Woods JS; Konoplev S; Bueso-Ramos CE; Reyes SR
Arch Pathol Lab Med; 2013 Nov; 137(11):1669-73. PubMed ID: 24168508
[TBL] [Abstract][Full Text] [Related]
6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
7. ImageStream promyelocytic leukemia protein immunolocalization: in search of promyelocytic leukemia cells.
Mirabelli P; Scalia G; Pascariello C; D'Alessio F; Mariotti E; Di Noto R; George TC; Kong R; Venkatachalam V; Basiji D; Del Vecchio L
Cytometry A; 2012 Mar; 81(3):232-7. PubMed ID: 22266986
[TBL] [Abstract][Full Text] [Related]
8. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
[TBL] [Abstract][Full Text] [Related]
9. [PML (promyelocytic leukemia). Oncogene].
Soussi T; de Thé H
Bull Cancer; 1999 Feb; 86(2):133. PubMed ID: 10094521
[No Abstract] [Full Text] [Related]
10. The puzzling multiple lives of PML and its role in the genesis of cancer.
Ruggero D; Wang ZG; Pandolfi PP
Bioessays; 2000 Sep; 22(9):827-35. PubMed ID: 10944585
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia with i(17)(q10) on G-banding and PML/RARA rearrangement by RT-PCR without evidence of PML/RARA rearrangement on FISH.
Huh J; Moon H; Chi H; Chung W
Int J Lab Hematol; 2009 Jun; 31(3):372-4. PubMed ID: 18294238
[No Abstract] [Full Text] [Related]
12. RT-PCR in acute promyelocytic leukemia: second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994.
Leukemia; 1996 Feb; 10(2):368-71. PubMed ID: 8637250
[TBL] [Abstract][Full Text] [Related]
13. [Progress in researches on the function of PML gene].
Zhou L; Chen G; Shen Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):132-5. PubMed ID: 10751540
[TBL] [Abstract][Full Text] [Related]
14. The PML nuclear compartment and cancer.
Doucas V; Evans RM
Biochim Biophys Acta; 1996 Dec; 1288(3):M25-9. PubMed ID: 9011178
[No Abstract] [Full Text] [Related]
15. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
16. An immunofluorescent assay for acute promyelocytic leukemia cells.
Samoszuk MK; Tynan W; Sallash G; Nasr S; Monczak Y; Miller WH
Am J Clin Pathol; 1998 Feb; 109(2):205-10. PubMed ID: 9583893
[TBL] [Abstract][Full Text] [Related]
17. Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice.
Lock RJ; Virgo PF; Kitchen C; Evely RS
Clin Lab Haematol; 2004 Apr; 26(2):101-6. PubMed ID: 15053803
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
Doucas V; Tini M; Egan DA; Evans RM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
[TBL] [Abstract][Full Text] [Related]
19. Translocation of the RAR alpha locus to the PML or PLZF gene in acute promyelocytic leukaemia.
Zelent A
Br J Haematol; 1994 Mar; 86(3):451-60. PubMed ID: 8043428
[No Abstract] [Full Text] [Related]
20. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic.
Andre C; Guillemin MC; Zhu J; Koken MH; Quignon F; Herve L; Chelbi-Alix MK; Dhumeaux D; Wang ZY; Degos L; Chen Z; de The H
Exp Cell Res; 1996 Dec; 229(2):253-60. PubMed ID: 8986606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
